Adialante

Adialante

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://adialante.com/

Last Round

Grant

Jun 19, 2025

Total Funding Raised

$2.97M

Company Overview

Adialante is a medical device company that develops deployable, clinical-grade MRI technology to make cancer screening more accessible.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Computing Hardware

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

mobile MRIimaging as a servicecompact MRIpoint-of-care MRIdiagnostic imagingprostate imagingmedical devicecancer screeningmobile medical clinicurology imagingper-scan feeorthopedic imagingrural healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adialante Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Adialante Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 19, 2025
SeedAug 30, 2024
GrantJun 30, 2024
GrantDec 1, 2023
GrantSep 27, 2023

Key People

Founding team and executive leadership

Parker Jenkins

Chief Operating Officer Co-Founder

Founding Team

Efraín Torres

CEO Co-Founder

Founding Team

Kyle King

Chief Financial Officer

Executive Team

Adialante Investors

Notable investors and investment history

Adialante Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Adialante Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adialante's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range7
Year Founded2023
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.